Researchers from Curtin University have discovered the likely' blood-to-brain pathway' that can lead to Alzheimer's disease, the most common cause of dementia worldwide....

-amyloid protein begins to accumulate in the brain some 20 years before Alzheimer's disease symptoms

217) which is indicative of neurodegeneration, and beta-amyloid 42 which, when built up, is associated

88 PET scanners to detect the build-up of toxic amyloid plaques in the brain, one of the lowest totals

Crystal Glover, a social psychologist and expert in equity in aging research who leads clinical trial recruitment of the Rush Alzheimer's Disease Research Center in Chicago, asked:" Is this even applicable to the groups that are most at risk?... " Is it because MCI( mild cognitive impairment) or early dementia type-symptoms in Blacks are caused by other reasons more so than Alzheimer's?... " Eisai's U.S. head Ivan Cheung told Reuters in an interview....

Crystal Glover, a social psychologist and expert in equity in aging research who leads clinical trial recruitment of the Rush Alzheimer's Disease Research Center in Chicago, asked:" Is this even applicable to the groups that are most at risk?... " Is it because MCI( mild cognitive impairment) or early dementia type-symptoms in Blacks are caused by other reasons more so than Alzheimer's?... " Eisai's U.S. head Ivan Cheung told Reuters in an interview....

Then every few years afterward, the study detected another so-called biomarker of brewing trouble. Scientists don’t know exactly how Alzheimer’s forms.... An abnormal tau protein that forms neuron-killing tangles is one of several co-conspirators. The new research, published in the New England Journal of Medicine, offers a timeline for how those abnormalities pile up. The study’s importance “ cannot be overstated, ” said Dr.... But last year a drug named Leqembi became the first approved with

Another experimental Alzheimer’s drug can modestly slow patients’ inevitable worsening — by about four to seven months, researchers reported Monday. Eli Lilly and Co.is seeking Food and Drug Administration approval of donanemab.... If cleared, it would be only the second Alzheimer’s treatment convincingly shown to delay the mind-robbing disease — after therecently approved Leqembifrom Japanese drugmaker Eisai. Advertisement “ Finally there’s some hope, right, that we can talk about, ” Lilly’s D

New research shows an experimental Alzheimer’s drug from Eli Lilly and Co. can modestly slow patients’ inevitable worsening, though it comes with safety concerns.... Print WASHINGTON— Another experimental Alzheimer’s drug can modestly slow patients’ inevitable worsening — by about four to seven months, researchers reported this week. Eli Lilly and Co.is seeking Food and Drug Administration approval of donanemab.... Advertisement “ We don’t cure the disease, ” he said....

Former president Pervez Musharraf's family on Friday clarified that he was not on ventilator but has been hospitalised for the last three weeks.... " He is not on the ventilator.... Pray for ease in his daily living." The family issued the statement after false news of his demise started circulating on social media after some Pakistani and Indian publications carried it....